Carbon nanotubes as a novel drug delivery system for anticancer therapy: a review

Abstract

Carbon nanotubes (CNTs) were discovered in 1991 and shown to have certain unique physicochemical properties, attracting considerable interest in their application in various fields including drug delivery. The unique properties of CNTs such as ease of cellular uptake, high drug loading, thermal ablation, among others, render them useful for cancer therapy. Cancer is one of the most challenging diseases of modern times because its therapy involves distinguishing normal healthy cells from affected cells. Here, CNTs play a major role because phenomena such as EPR, allow CNTs to distinguish normal cells from affected ones, the Holy Grail in cancer therapy. Considerable work has been done on CNTs as drug delivery systems over the last two decades. However, concerns over certain issues such as biocompatibility and toxicity have been raised and warrant extensive research in this field.Uniterms: Carbon nanotubes/properties. Carbon nanotubes/use/drugs delivery. Single-Walled Carbon Nanotube. Multiwalled Carbon Nanotube. Anticancer drugs/delivery. Cancer/therapy. Drugs/delivery.Os nanotubos de carbono foram descobertos em 1991 e suas propriedades físico-químicas únicas demonstradas, despertando interesse em sua aplicação em vários campos, incluindo a entrega liberação de fármacos. As propriedades únicas dos nanotubos de carbono, tais como a facilidade de captação pela célula, carga alta de fármaco, ablação térmica, entre outras, tornaram-nos úteis para terapia de câncer, uma das doenças mais difíceis dos tempos modernos, pois sua terapia envolve a distinção entre as células normais saudáveis e as afetadas pela doença. Os nanotubos de carbono têm um papel importante nessa área porque fenômenos como EPR permitem que estes possam distinguir as células normais das afetadas, que é o Santo Graal na terapia do câncer. Trabalho considerável tem sido feito ao longo das duas últimas década com nanotubos de carbono, como sistemas de liberação de fármacos. No entanto, preocupações sobre algumas questões, como biocompatibilidade e toxicidade, surgiram ao longo do tempo, demandando extensas pesquisa nesse campo. Unitermos: Nanotubos de carbono/propriedades. Nanotubos de carbono/uso/liberação de fármacos. Nanotubo de carbono de parede única. Nanotubo de parede múltipla. Fármacos anticancer/liberação. Cancer/tratamento. Fármacos/liberação.

Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells

“…16 Recently, scientists have revealed several strategies, such as loading synthetic analogs from turmeric, designing metabolic inhibitors and liposomal formulations, and nanoparticles of curcumin, to overcome these problems. [17][18][19][20] Dendrosome was introduced as a novel neutral, amphipathic, and biodegradable nanocarrier for a gene delivery system in the authors' research group. 21,22 The high potential of dendrosome as a gene porter led to the hypothesis that it can be exploited as a vehicle for curcumin delivery.…”

Malign plevral mezotelyomada ilaç taşıyıcı nanosistemler

“…Bu dezavantajlar arasında; hızlı topaklanma eğilimi, bazı zamanlarda hedef bölgeye gitmeden ilaç salımı yapma, suda çözünebilen moleküllerin yüklenmesin-deki zorluk ve bazı taşıma sistemlerinin üretiminde-ki zorluk yer almaktadır (86)(87)(88)(89). Literatürde ilaç yüklemede kullanılan KNT ile ilgili heyecan verici gelişmeler olmasına rağmen, sitotoksik etkilerinin gösterildiği araştırmalar da vardır.…”

Nano drug delivery in oral cancer therapy: An emerging avenue to unveil

“…[23] Safety of these nanotubes has to be considered because of its needle-like fiber shape [8] and issues with respect to their toxicity still remains obscure and inconclusive, due to which probably no clinical trials have been tried by using carbon nanotubes. [32,34] …”